Venom soars past $800M at the worldwide box office… surpassing last year’s Wonder Woman

Sony’s hit Spider-Man spin-off Venom has passed another big box office milestone this weekend.

The movie has now earned $822.5 million worldwide, surpassing the $821.8 million take of one of last year’s biggest superhero movies, Wonder Woman, according to Forbes.

Most of those earnings came from overseas, with $211.7 million coming from its domestic haul while $610.8 million was from foreign markets.

Taking a bite out of the box office: Venom passes a big box office milestone, earning $800 million worldwide

Venom was produced on a relatively modest $100 million budget, with Forbes projecting its worldwide take will be roughly $865 million.

It also has the distinction of being the highest grossing superhero ‘origin story’ of all time. 

(That is if you don’t count Black Panther ($1.346 billion), since the character was introduced in Captain America: Civil War.)

Venom will be among the most profitable superhero movies of all time, behind only The Mask ($350 million worldwide, $23 million budget), Teenage Mutant Ninja Turtles ($200 million worldwide, $14 million budget), Batman ($411 million worldwide, $35 million budget), Deadpool ($783 million worldwide, $58 million budget) and Chronicle ($126 million worldwide, $12 million budget).

Big hit: Venom was produced on a relatively modest $100 million budget, with Forbes projecting its worldwide take will be roughly $865 million

Big hit: Venom was produced on a relatively modest $100 million budget, with Forbes projecting its worldwide take will be roughly $865 million

As of now, Venom’s $211.7 million take is good for ninth biggest blockbuster of the year, but it could jump to as high as sixth place.

At just over $210million Venom is easily within striking distance of Solo: A Star Wars Story ($213.8 million), Ant-Man and the Wasp ($216.6 million) and Mission: Impossible – Fallout ($220.2 million)

Still, Venom likely won’t surpass Deadpool 2’s $318.5 million take for fifth place.

Origin story: It also has the distinction of being the highest grossing superhero 'origin story' of all time, but that is if you don't count Black Panther ($1.346 billion), since the character was introduced in Captain America: Civil War

Origin story: It also has the distinction of being the highest grossing superhero ‘origin story’ of all time, but that is if you don’t count Black Panther ($1.346 billion), since the character was introduced in Captain America: Civil War

On the worldwide box office charts, Venom’s $822.5 million is good for sixth place, and unless it’s surpassed by one of the potential blockbusters in December, it will likely stay put.

Venom is still very far behind The Incredibles 2 ($1.240 billion), Jurassic World: Fallen Kingdom ($1.304 billion), Black Panther ($1.346 billion) and Avengers: Infinity War ($2.046 billion).

While Venom is clearly a hit with audiences, critics didn’t respond to it quite as well, with just a 29% rating on Rotten Tomatoes.

Eddie and Anne: Venom stars Tom Hardy as Eddie Brock, who, with the help of an alien symbiote, turns into the villainous Venom, with Michelle Williams playing Anne Weying

Eddie and Anne: Venom stars Tom Hardy as Eddie Brock, who, with the help of an alien symbiote, turns into the villainous Venom, with Michelle Williams playing Anne Weying

Venom stars Tom Hardy as Eddie Brock, who, with the help of an alien symbiote, turns into the villainous Venom, with Michelle Williams playing Anne Weying.

Sony has set dates for unspecified movies on July 10, 2020 and October 5, 2020, with the October movie believed to be a sequel to Venom.

The sequel will likely feature a character teased in the post-credit sequence, Carnage, played by Woody Harrelson.

Thumbs up: While Venom is clearly a hit with audiences, critics didn't respond to it quite as well, with just a 29% rating on Rotten Tomatoes

Thumbs up: While Venom is clearly a hit with audiences, critics didn’t respond to it quite as well, with just a 29% rating on Rotten Tomatoes

Read more at DailyMail.co.uk